IOSP vs NEU: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: IOSP is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. IOSP and NEU share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined IOSP and NEU exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Innospec Inc. is an Englewood, Colorado specialty chemicals company that listed in 1998 as Octel Corp and took the Innospec name in 2006. It reports three segments. Fuel Specialties, the profit engine, sells combustion improvers, detergents, cold flow additives and stabilizers to refiners, fuel marketers and the aviation gasoline market, and produced ~$185.7 million of revenue at a ~36.6 percent gross margin in the second quarter of 2026. Performance Chemicals supplies surfactants and formulation ingredients for personal care, home care and industrial customers, contributing ~$190.3 million at a much thinner ~17.3 percent gross margin. Oilfield Services sells production and completion chemicals plus drag reducing agents, which let pipeline operators push more volume through existing lines, and added ~$115.4 million. About ~2,450 employees serve customers across the Americas, EMEA and Asia Pacific.

Full IOSP guide

NewMarket Corporation is a Richmond, Virginia holding company that operates primarily through Afton Chemical and Ethyl Corporation, which develop, blend, and sell chemical additives that improve the performance of engine oils, transmission fluids, and fuels. The additives are a small fraction of the cost of the finished lubricant but are technically critical, which gives the business unusually sticky customer relationships and consistent margins. More recently the company has built out a smaller Specialty Materials segment (including the AMPAC and Calca acquisitions) that touches areas such as specialty ammonium perchlorate and other niche materials.

Full NEU guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• IOSP drivers: Fuel Specialties carries the earnings; Oilfield Services rebuilding on drag reducing agents.
• NEU drivers: Margin resilience and mix discipline; Cash generation and capital returns.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Performance Chemicals runs at roughly a ~17 percent gross margin, so modest moves in raw material cost or personal care demand swing a disproportionate amount of operating income, and the North Carolina site has not yet returned to normal production. For NEU, petroleum additives demand is tied to global lubricant and fuel consumption, so a soft industrial and automotive environment directly pressures shipments, as seen in recent quarters.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick IOSP if you believe its drivers more; NEU if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the IOSP and NEU guides.

IOSP. At roughly ~$94 a share and a market cap near ~$2.31 billion, Innospec trades at about ~19 times trailing earnings and ~1.25 times sales, with enterprise value pulled down to ~$2.11 billion by the net cash position. Trailing growth rates flatter the picture because the comparison base includes a ~$155.6 million non-cash settlement charge taken in 2024 when the company bought out its UK pension scheme, cutting that year's net income to ~$35.6 million against ~$139.1 million in 2023. Return on equity near ~9 percent and return on invested capital near ~11 percent read as solid rather than exceptional, which is roughly where the multiple sits.

NEU. NewMarket carries a mid-teens P/E, in line with a mature specialty chemicals name that grows slowly but returns lots of cash. Full-year 2025 net income of about $419 million was down from 2024, and Q1 2026 continued the softer trend with revenue near $670 million. The valuation reflects steady margins and capital returns rather than expectations of rapid growth.

Headline figures (approximate, August 2026): IOSP shows revenue (ttm) ~$1.84 billion, with Q2 2026 revenue of ~$491.4 million, up ~12% year over year, diluted eps (ttm) ~$4.90, including ~$1.25 GAAP (~$1.27 adjusted) in Q2 2026, operating and net margin ~8.1% operating, ~6.6% net on a trailing basis, p/e ~19x trailing, ~16x forward; NEU shows revenue (ttm) ~$2.7B, net income (fy2025) ~$419M, diluted eps (fy2025) ~$44.44, q1 2026 net income ~$118M (~$12.62/sh).

IOSP and NEU are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined IOSP and NEU exposure against your real portfolio. It is not an investment adviser.